Scientists have been awarded £900,000 from Cancer Research UK to launch a ground-breaking clinical trial for people with lung cancer.
Leeds scientists have discovered how drug-like small molecules can regulate the activity of therapeutically relevant ion channels - and their findings could transform ongoing drug development efforts.
University staff and students have been recognised for their role in helping to establish the Alderley Park Lighthouse Laboratory in Cheshire, a key part of the Government’s COVID-19 testing strategy.
The benefits of giving chemotherapy before surgery to bowel cancer patients will be further explored in a new £3.4 million trial, one of three awarded regional funding.
A lung cancer trial aiming to detect disease in higher risk patients before they show symptoms has caught dozens of cases early.